Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Multiple Sclerosis (MS), confirmed using a specific recognised diagnostic method called the McDonald Criteria
- People whose MS is the relapsing-remitting type (where symptoms flare up and then partially or fully recover)
- People whose MS disability level is rated as mild, scoring between 0 and 3 on a scale called the PDDS (confirm with trial site for exact scoring details)
- People aged between 18 and 45 years old
- People who have mild difficulties with memory or thinking
- People who have mild to moderate difficulties with balance
- People who experience dizziness, vertigo, or unstable vision related to their MS
- People whose first language is Arabic, as clear communication in Arabic is required for the tasks involved
- People who are physically able to participate in the two types of treatment used in the trial: mental movement practice (motor imagery) and balance/dizziness rehabilitation exercises
Who may not be able to join:
- People who have another neurological condition in addition to MS, or whose MS is the progressive type (rather than relapsing-remitting)
- People whose dizziness or balance problems are caused by a non-MS condition, such as BPPV or Meniere's disease, as this could interfere with the treatment being studied
- People with severe psychiatric conditions such as schizophrenia or bipolar disorder
- People with severe balance problems
- People experiencing severe fatigue
- People with unstable or serious medical conditions, such as heart or lung disease, active infections, severely uncontrolled diabetes, or severe vision problems
- People with severe difficulties with memory or thinking
- People who are pregnant
- People with advanced physical disability, such as those who use a wheelchair or are unable to stand
- People who are currently taking medications that suppress or reduce the vestibular (balance and dizziness) system (confirm specific medications with the trial site)
- People who do not speak Arabic as their first language
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Merve Yılmaz Menek, Assoc. Prof, Assoc. Prof. Merve Yılmaz Menek
Phone: +201040131964
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Cognitive Function (Montreal Cognitive Assessment [MoCA] Score); Change in Balance Berg Balance Scale \[ABBS] Score); Change in Vestibular Function (Dynamic Visual Acuity [DVA] Test); Change in Vestibular Function (Head Impulse Test [HIT]); Change in Cognitive Function (Brief International Cognitive Assessment for MS \[BICAMS] Composite Score; Change in balance (Timed Up and Go [TUG] Time); Change in Disability Status (Patient-Determined Disease Steps \[PDDS] Score)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.